2015
Autores
Spiliopoulou, M; Rodrigues, PP; Menasalvas, E;
Publicação
Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining
Abstract
In year 2015, we experience a proliferation of scientific publications, conferences and funding programs on KDD for medicine and healthcare. However, medical scholars and practitioners work differently from KDD researchers: their research is mostly hypothesis-driven, not data-driven. KDD researchers need to understand how medical researchers and practitioners work, what questions they have and what methods they use, and how mining methods can fit into their research frame and their everyday business. Purpose of this tutorial is to contribute to this learning process. We address medicine and healthcare; there the expertise of KDD scholars is needed and familiarity with medical research basics is a prerequisite. We aim to provide basics for (1) mining in epidemiology and (2) mining in the hospital. We also address, to a lesser extent, the subject of (3) preparing and annotating Electronic Health Records for mining.
2015
Autores
Spiliopoulou, M; Rodrigues, PP; Menasalvas, E;
Publicação
Proceedings of the 21th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining - KDD '15
Abstract
2015
Autores
Jr., CT; Rodrigues, PP; Kane, B; Marques, PMdA; Traina, AJM;
Publicação
CBMS
Abstract
2022
Autores
Maksimenko, J; Rodrigues, PP; Nakazawa Miklasevica, M; Pinto, D; Miklasevics, E; Trofimovics, G; Gardovskis, J; Cardoso, F; Cardoso, MJ;
Publicação
JMIR FORMATIVE RESEARCH
Abstract
Background: Approximately 62% of patients with breast cancer with a pathogenic variant (BRCA1 or BRCA2) undergo primary breast-conserving therapy. Objective: The study aims to develop a personalized risk management decision support tool for carriers of a pathogenic variant (BRCA1 or BRCA2) who underwent breast-conserving therapy for unilateral early-stage breast cancer. Methods: We developed a Bayesian network model of a hypothetical cohort of carriers of BRCA1 or BRCA2 diagnosed with stage I/II unilateral breast cancer and treated with breast-conserving treatment who underwent subsequent second primary cancer risk-reducing strategies. Using event dependencies structured according to expert knowledge and conditional probabilities obtained from published evidence, we predicted the 40-year overall survival rate of different risk-reducing strategies for 144 cohorts of women defined by the type of pathogenic variants (BRCA1 or BRCA2), age at primary breast cancer diagnosis, breast cancer subtype, stage of primary breast cancer, and presence or absence of adjuvant chemotherapy. Results: Absence of adjuvant chemotherapy was the most powerful factor that was linked to a dramatic decline in survival. There was a negligible decline in the mortality in patients with triple-negative breast cancer, who received no chemotherapy and underwent any secondary risk-reducing strategy, compared with surveillance. The potential survival benefit from any risk-reducing strategy was more modest in patients with triple-negative breast cancer who received chemotherapy compared with patients with luminal breast cancer. However, most patients with triple-negative breast cancer in stage I benefited from bilateral risk-reducing mastectomy and risk-reducing salpingo-oophorectomy or just risk-reducing salpingo-oophorectomy. Most patients with luminal stage I/II unilateral breast cancer benefited from bilateral risk-reducing mastectomy and risk-reducing salpingo-oophorectomy. The impact of risk-reducing salpingo-oophorectomy in patients with luminal breast cancer in stage I/II increased with age. Most older patients with the BRCA1 and BRCA2 pathogenic variants in exons 12-24/25 with luminal breast cancer may gain a similar survival benefit from other risk-reducing strategies or surveillance. Conclusions: Our study showed that it is mandatory to consider the complex interplay between the types of BRCA1 and BRCA2 pathogenic variants, age at primary breast cancer diagnosis, breast cancer subtype and stage, and received systemic treatment. As no prospective study results are available at the moment, our simulation model, which will integrate a decision support system in the near future, could facilitate the conversation between the health care provider and patient and help to weigh all the options for risk-reducing strategies leading to a more balanced decision.
2024
Autores
Rodrigues, MG; Rodrigues, JD; Moreira, JA; Clemente, F; Dias, CC; Azevedo, LF; Rodrigues, PP; Areias, JC; Areias, ME;
Publicação
CHILD CARE HEALTH AND DEVELOPMENT
Abstract
PurposeTo develop, implement and assess the results of psychoeducation to improve the QoL of parents with CHD newborns.MethodsParticipants were parents of inpatient newborns with the diagnosis of non-syndromic CHD. We conducted a parallel RCT with an allocation ratio of 1:1 (intervention vs. control), considering the newborns, using mixed methods research. The intervention group received psychoeducation (Parental Psychoeducation in CHD [PPeCHD]) and the usual routines, and the control group received just the regular practices. The allocation concealment was assured. PI was involved in enrolling participants, developing and implementing the intervention, data collection and data analysis. We followed the Consolidated Standards of Reporting Trials (CONSORT) guidelines.ResultsParents of eight newborns were allocated to the intervention group (n = 15 parents) and eight to the control group (n = 13 parents). It was performed as an intention-to-treat (ITT) analysis. In M2 (4 weeks), the intervention group presented better QoL levels in the physical, psychological, and environmental domains of World Health Organization Quality of Life instrument (WHOQOL-Bref). In M3 (16 weeks), scores in physical and psychological domains maintained a statistically significant difference between the groups.ConclusionsThe PPeCHD, the psychoeducational intervention we developed, positively impacted parental QoL. These results support the initial hypothesis. This study is a fundamental milestone in this research field, adding new essential information to the literature.
2024
Autores
Leite, S; Mota, B; Silva, AR; Commons, ML; Miller, PM; Rodrigues, PP;
Publicação
PLOS ONE
Abstract
Several studies demonstrate that the structure of the brain increases in hierarchical complexity throughout development. We tested if the structure of artificial neural networks also increases in hierarchical complexity while learning a developing task, called the balance beam problem. Previous simulations of this developmental task do not reflect a necessary premise underlying development: a more complex structure can be built out of less complex ones, while ensuring that the more complex structure does not replace the less complex one. In order to address this necessity, we segregated the input set by subsets of increasing Orders of Hierarchical Complexity. This is a complexity measure that has been extensively shown to underlie the complexity behavior and hypothesized to underlie the complexity of the neural structure of the brain. After segregating the input set, minimal neural network models were trained separately for each input subset, and adjacent complexity models were analyzed sequentially to observe whether there was a structural progression. Results show that three different network structural progressions were found, performing with similar accuracy, pointing towards self-organization. Also, more complex structures could be built out of less complex ones without substituting them, successfully addressing catastrophic forgetting and leveraging performance of previous models in the literature. Furthermore, the model structures trained on the two highest complexity subsets performed better than simulations of the balance beam present in the literature. As a major contribution, this work was successful in addressing hierarchical complexity structural growth in neural networks, and is the first that segregates inputs by Order of Hierarchical Complexity. Since this measure can be applied to all domains of data, the present method can be applied to future simulations, systematizing the simulation of developmental and evolutionary structural growth in neural networks.
The access to the final selection minute is only available to applicants.
Please check the confirmation e-mail of your application to obtain the access code.